Drug Profile
Influenza A virus vaccine H5N1 - iBio
Alternative Names: HAI-05 Influenza Vaccine; Pandemic avian influenza vaccine - iBio; Plant virus derived influenza vaccine - iBioLatest Information Update: 28 Dec 2017
Price :
$50
*
At a glance
- Originator INB:Biotechnologies
- Developer iBio Inc
- Class Influenza A virus H5N1 vaccines; Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype
Most Recent Events
- 28 Dec 2017 No recent reports of development identified for phase-I development in Influenza-A-virus-H5N1-subtype(In volunteers) in USA (IM)
- 30 Nov 2015 Phase I development is ongoing in USA
- 30 Nov 2015 iBio has patent protection for iBioModulator™ thermostable immunomodulator protein technology in China